Valve-in-valve (ViV) transcatheter procedures for a failed aortic bioprosthesis are associated with a lower risk of in-hospital mortality compared with a repeat surgical aortic valve replacement, but ...
June 16, 2011 (Montreal, Quebec City) — Among patients with aortic stenosis who undergo transcatheter aortic-valve implantation (TAVI), in-stent flow acceleration affects echo measurements used to ...
COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc. today announced successful results in an additional 5 patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV™) ...
The first human transcatheter aortic valve implantation (TAVI) in 2002, and several subsequent single-center series, showed the feasibility of this new approach for the treatment of patients with ...
Aortic valve disease is a condition that occurs when your aorta (the main artery of your body) and left ventricle (the lower left chamber of your heart) malfunction. The aortic valve determines how ...
New data showing five-year outcomes at a single center with the very earliest transcatheter aortic valve implant (TAVI) devices indicate that they are durable and "may last as long as many surgical ...
Cardiovascular diseases continue to represent a global health crisis affecting millions of people worldwide. These conditions necessitate urgent medical intervention, as cardiovascular diseases ...
As transcatheter aortic valve implantation (TAVI) gains increasing acceptance, cardiologists and surgeons are exploring additional patient populations who may benefit from the procedure. A new paper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results